To evaluate the potential use of newly developed SCD inhibitors as novel anticancer agents, we tested the potential growth inhibitory effect of CVT-11127, a novel small-molecule inhibitor of SCD activity, on several lung cancer cell lines. The gene discussed is SCD; the disease is lung cancer.